Relationship btw amount of drug and effect Flashcards

0
Q

what relationships are linear?

A

dose of drug and [drug] at target site

[drug-receptor complex] and response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Dose response causal chain

A

dose of drug -> drug at target site -> drug-receptor complex -> response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what relationships are non linear?

A

[drug] at target site -> [drug receptor complex]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the dominant non linear relationship in the causal chain?

A

formation of the drug-receptor complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does the drug-receptor complex determine?

A

the shape of the dose-effect and the concentration-effect relationships

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A plot of [D]free versus [R-D] is

A

hyperbolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A plot of log [D]free versus [R-D] is

A

sigmodial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A plot of [D]free versus response is

A

hyperbolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A plot of log [D]free versus response is

A

sigmoidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The [drug] which causes 1/2 maximal response is called

A

EC50 and corresponds to the Kd if there is a linear relationship between [D-R] and response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Potency refers to

A

EC50 of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when the assumption of linearity does not hold, the EC50

A

no longer approximates the Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Spare receptors

A

when present, the EC50 will be much smaller than the Kd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tissue express “spare receptors” when

A

only a small fraction of the receptor population must be occupied by drug to give a maximal response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The lower the Ec50, the

A

greater the potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A low Kd and high number of spare receptors increases

A

the potency of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Efficacy

A

refers to the maximal response of a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

the greater the maximal response,

A

the greater the efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The more effectively a drug engages signal-transduction systems in a cell per unit receptor occupied, the

A

greater is the efficacy of that drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

best in class

A

Full agonist and any drug that generates a maximal response equal to the “best in class” is also referred to as “full agonist”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Partial agonist

A

any drug that generates a maximal response less than that elicited by the “best in class”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Even if Drug A is a full agonist and Drug B is a partial agonist, they can still the same what?

22
Q

Shape of dose versus Response

A

Hyperbolic

23
Q

shape of Log dose vs. Response

24
ED50
dose which causes 1/2 maximal response | affected by Kd and EC50 it is greatly influenced by apparent volume in which drug is distributed
25
ED50 is never equal to
EC50 or Kd
26
characteristics of surmountable antagonist
produces parallel shift in concentration-response curve of agonist Full effect of agonist can be restored by increasing concentration of agonist
27
Common mechanism of surmountable antagonism
competitive interaction between agonist (potency and efficacy) and antagonist (potent but no or little efficacy) at binding site on receptor
28
The net effect of a competitive antagonist is to increase the apparent
Kd, or said differently to decrease the apparent potency of the agonist
29
Addition of competitive antagonist causes
apparent shift in EC50 for the agonist | because takes higher concentration for a response
30
Characteristics of insurmountable antagonist
produce non-parallel shift in concentration-response curve of agonist full effect of agonist cannot be restored by increasing concentration of agonist
31
Common mechanism of insurmountable antagonism
competitive but irreversible binding of antagonist to binding site on receptor allosteric modulation of receptor by antagonist so as to attenuate coupling of receptor to signal transduction blockade of signal transduction "downstream" of receptor
32
Quantal effect
is an effect that is either present or absent
33
Quantal concentration
or dose response curve is a plot of concentration or dose versus % patients in the population who exhibit the quantal response at the given concentration or dose
34
we represent the effect of a drug in an Individual as a concentration or
dose response curve in which the graded effects of the drug are related to concentrations or doses of the drug
35
we represent the effect of a drug in a Population as a concentration or
dose response curve in which the Quantal effect of the drug is related to concentrations or doses of the drug
36
If quantal response happens to be death then ED50 is called
LD50
37
Although both graded and quantal relationships have ED50s and EC50s, the parameter are
NOT the same for graded and Quantal relationships
38
Graded relationships
Ed50s and EC50s indicate doses and concentrations that cause 1/2 maximal response in a given individual
39
Quantal relationships
ED50s and Ec50s indicate doses and concentrations that cause 1/2 of the population to respond
40
Since the log dose-response curve is sigmoidal, increasing
the dose of a drug when the response is submaximal will enhance the therapeutic effect
41
Since the log dose-response curve is sigmoidal, increasing
the dose of a drug when the response is maximal will not improve the therapeutic effect but may subject the patient to toxicity
42
The log dose-response curve is sigmoidal, regardless of whether the
"response" is therapeutic or toxic
43
The safety of a drug can be assessed by examining the log dose-response curves for
therapeutic versus toxic effects
44
The more separation between the therapeutic log dose-response curves and the toxic log dose-response curves, the
safer the drug
45
A drug with low potency and high efficacy may be better than a drug with
low efficacy and high potency
46
Potency is a determinant of
how much of the drug must be given to obtain a "ceiling" effect
47
Efficacy refers to the magnitude of
the "ceiling" effect
48
In an antagonist is being employed to block the effect of an agnoist, it is important to know whether the antagonist is of
surmountable or insurmountable type
49
Dose of insurmountable antagonist usually does not need upward adjustment as amount of
agonist in body increases
50
Dose of surmountable antagonist must be increased if amount of agonist (endogenous or exogenous) in the patient
increases
51
Graded dose/concentration relationships help to understand
how changing dose of drug will effect the degree of response of an individual patient
52
Quantal dose/concentration relationships help to understand
how changing dose of drug will effect the % of your patients who will experience a defined response